Similar Articles
1091 Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
1092 Pediatric hepatocellular carcinoma
1093 Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma
1094 Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
1095 Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
1096 Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound
1097 Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
1098 Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions
1099 Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma
1100 Fourth-generation quinolones in the treatment of Helicobacter pylori infection: A meta-analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA